BioSpace News Archive

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide a corporate update and report financial results for the first quarter ended March 31, 2022, on Thursday, May 5, 2022.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its first quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 5, 2022.

CooperCompanies announced that Cooper and Cook Medical have each received a request for additional information from the U.S. Federal Trade Commission in connection with Cooper’s pending acquisition of Cook Medical’s Reproductive Health business.

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced that Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals, will participate in a fireside chat at the B. Riley 2022 Virtual Neuro & Ophthalmology Conference.

DBV Technologies announced that it will hold its Ordinary and Extraordinary General Meeting on May 12, 2022, at 8:30 a.m. CEST at the Company’s headquarters located at 177-181 Avenue Pierre Brossolette – 92120 Montrouge, France.

AREV Life Sciences Global Corp. (CSE: AREV) (OTC: AREVF) (“AREV” or the “Company”) announced today its initial research engagement with TransBIOTech.

Spectrum Dynamics announced the worldwide deployment of its TruCorr Attenuation Correction software across the United States, Europe, and Asia.

NeoSpectra by Si-Ware, the creator of NeoSpectra material analysis solutions built on single-chip FT-NIR spectrometers, announced a partnership with AB Vista’s Aunir, a global leader in the development and supply of near infrared reflectance spectroscopy calibrations.

VistaGen Therapeutics, Inc. announced that researchers will present preclinical data supporting the differentiated mechanism of action (MOA) for VistaGen’s lead product candidate, PH94B, at two upcoming major scientific congresses.

Artivion, Inc announced today that first quarter 2022 financial results will be released on Thursday, May 5, 2022 after the market closes.